Poliovirus Receptor Antikörper (Alexa Fluor 680)
Kurzübersicht für Poliovirus Receptor Antikörper (Alexa Fluor 680) (ABIN6900039)
Target
Alle Poliovirus Receptor (PVR) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- PVR Conjugated Antibody
-
-
anti-Poliovirus Receptor (PVR) (AA 21-343) antibody
PVR Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 6D2D6 unconjugated
anti-Poliovirus Receptor (PVR) (AA 22-255) antibodyPVR Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) antibodyPVR Reaktivität: Maus ELISA, FACS Wirt: Kaninchen Chimeric 3F1 unconjugated Recombinant Antibody
anti-Poliovirus Receptor (PVR) (AA 1-417) antibodyPVR Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) (AA 56-309) antibodyPVR Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) (AA 220-345) antibodyPVR Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) (Internal Region) antibodyPVR Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) (AA 314-342), (C-Term) antibodyPVR Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB41981 unconjugated
anti-Poliovirus Receptor (PVR) (AA 21-343) antibodyPVR Reaktivität: Human ELISA, FACS Wirt: Kaninchen Monoclonal DM146 unconjugated
anti-Poliovirus Receptor (PVR) (AA 314-342) antibodyPVR Reaktivität: Human WB, IHC, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- AF680 conjugated: most applications: 1: 50 - 1: 250
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C for 6 months.
-
-
- Poliovirus Receptor (PVR)
-
Andere Bezeichnung
- PVR
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interaktom
Target
-
